Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NxStage Medical Inc (NASDAQ:NXTM)

26.02
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
20.45
Today|||52-Week Range
30.80
-0.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues93.0M96.8M96.2M97.3M
 
 
 
 
 
Cost of Goods Sold45.5M46.4M46.7M48.9M
 
 
 
 
 
Depreciation And Amortization8.7M8.5M8.4M8.5M
 
 
 
 
 
 
Operating ExpensesGross Income38.8M41.9M41.1M40.0M
 
 
 
 
 
General Expenses40.0M42.9M43.2M48.9M
 
 
 
 
 
Other Operating Expenses0.00133.0K98.0K86.0K
 
 
 
 
Research And Development7.6M9.5M9.0M11.2M
 
 
 
 
 
Total Operating Expenses94.2M97.9M98.4M106.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-1.1M-2.2M-9.0M
 
 
 
 
 
Extraordinary Charge-500.0K0.000.000.00
 
 
Interest Expense On Debt227.0K203.0K224.0K168.0K
 
 
 
 
 
Other Expenses-423.0K-871.0K-200.0K759.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.3M-2.2M-2.6M-8.4M
 
 
 
 
 
Income Taxes-95.0K-613.0K-22.0K-469.0K
 
 
 
 
 
Minority Interest-822.0K-352.0K-490.0K-32.0K
 
 
 
 
 
Net Income-1.6M-1.2M-2.1M-8.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS64.8M65.3M65.8M66.1M
 
 
 
 
 
Shares To Calculate EPS Diluted64.8M65.3M65.8M66.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.03-$0.14
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.03-$0.14